AG真人官方

BitMine Immersion Technologies (NYSE AMERICAN: BMNR) has announced a significant $250 million private placement through the sale of 55,555,556 shares at $4.50 per share. The transaction, expected to close around July 3, 2025, was led by MOZAYYX with participation from notable investors including Founders Fund, Pantera, and others.

In a strategic move, the company plans to use the proceeds to acquire Ethereum (ETH) as its primary treasury reserve asset, increasing its existing treasury holdings by over 16x. The initiative will be supported by partnerships with FalconX, Kraken, and Galaxy Digital, alongside existing custody partners BitGo and Fidelity Digital.

Notably, Thomas Lee, Founder of Fundstrat and CIO of Fundstrat Capital, has been appointed as Chairman of the Board of Directors effective immediately. The private placement was conducted under Section 4(a)(2) of the Securities Act and/or Regulation D, with ThinkEquity, LLC acting as the placement agent.

Artelo Biosciences (Nasdaq: ARTL) has announced positive results from its first-in-human Phase 1 Single Ascending Dose (SAD) study of ART26.12, a novel non-opioid pain treatment candidate. The study, involving 49 subjects, demonstrated favorable safety and pharmacokinetic profiles for the first orally active Fatty Acid Binding Protein 5 (FABP5) inhibitor tested in humans.

Key findings from the study include excellent safety results with only mild, transient, and self-resolving adverse events, predictable pharmacokinetics with dose-dependent linear absorption, and a wide safety margin between therapeutic plasma concentrations and highest exposure levels. The drug represents a first-in-class approach targeting the multibillion-dollar pain management market.

The chronic pain therapeutics market exceeded $97 billion globally in 2023 and is projected to surpass $159 billion by 2030. A Multiple Ascending Dose study is planned to commence in Q4 2025 to further evaluate ART26.12's safety, tolerability, and pharmacokinetics with repeated dosing.

Unicycive Therapeutics (Nasdaq: UNCY) announced receiving a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Oxylanthanum Carbonate (OLC), intended to treat hyperphosphatemia in chronic kidney disease patients on dialysis.

The CRL cited deficiencies at a third-party manufacturing vendor unrelated to OLC itself. The FDA did not raise concerns about pre-clinical, clinical, or safety data. The company has identified a second manufacturing vendor that has already produced OLC drug product and could help resolve the Clinical Manufacturing and Controls (CMC) issues.

Unicycive plans to request a Type A meeting with the FDA to discuss next steps. The company reports an unaudited cash balance of approximately $20.7 million, with runway expected into the second half of 2026.

INmune Bio (NASDAQ: INMB) has reported results from its Phase 2 MINDFuL trial evaluating XPro鈩�, a selective soluble TNF inhibitor, in early Alzheimer's Disease (AD). While the modified intent-to-treat population (n=200) did not meet the primary cognitive endpoint, a predefined subgroup of amyloid-positive early AD patients with two or more biomarkers of inflammation (n=100) showed positive results.

Key findings in the subgroup demonstrated:

• Clinical benefit on the primary endpoint EMACC (effect size: 0.27)
• Improvement on the Neuropsychiatric Inventory (effect size: -0.24)
• Biological benefit in blood levels of pTau217 (effect size: -0.20)

The treatment was well-tolerated with no occurrences of ARIA-E or ARIA-H, even in high-risk ApoE4+/+ patients. The most common adverse events were injection site reactions, affecting 80% of the XPro鈩� group. The company plans to file for Breakthrough Therapy Designation with the FDA and schedule an End-of-Phase 2 meeting in Q4 2025 to define the path for a pivotal trial.

Robinhood (NYSE:HOOD) has announced a comprehensive expansion of its crypto and investment offerings, marking a significant evolution in its business model. The company unveiled several major initiatives including:

The launch of US stock and ETF tokens in the EU, allowing European customers to trade 200+ tokenized US securities with zero commissions. The company is also developing its own Layer 2 blockchain based on Arbitrum to facilitate tokenized real-world assets.

Additional key announcements include the introduction of crypto perpetual futures with up to 3x leverage for EU customers, the launch of crypto staking for Ethereum and Solana in the US, and several platform enhancements including Smart Exchange Routing, Tax Lots, and Advanced Charts. The company is also offering a limited-time 1% deposit boost for crypto transfers, which can increase to 2% if total deposits reach $500M.

The expansion will extend Robinhood's reach to over 400 million people across 30 EU and EEA countries, transforming its European app from a crypto-only platform to a comprehensive investment solution.

Gorilla Technology Group (NASDAQ: GRRR) has announced a $105 million registered direct offering of common stock, with shares priced at $17.50 per ordinary share. The offering consists of 6,000,000 ordinary shares (or pre-funded warrants) and is primarily led by a $100 million investment from a new fundamental institutional investor, with additional participation from an existing large shareholder.

The offering is expected to close around July 2, 2025, subject to customary closing conditions. Titan Partners Group, a division of American Capital Partners, is serving as the sole placement agent. The proceeds will be utilized for working capital needs, including establishing performance guarantees, bid bonds, statutory capital reserves for project bids, supporting previously announced acquisitions, and other general corporate purposes.

The offering is being conducted through an effective shelf registration statement on Form F-3 previously filed with the SEC on August 17, 2023, and declared effective on August 29, 2023.

Synopsys (NASDAQ: SNPS) and Ansys (NASDAQ: ANSS) provided an update on their pending acquisition's regulatory approval status. The companies have successfully obtained merger clearance in all jurisdictions except China, where they are in advanced discussions with the State Administration for Market Regulation (SAMR).

The companies emphasized that the merger approvals received so far were based on the transaction's merits and its expected benefits for stakeholders and future technology innovation. They continue to work collaboratively with Chinese regulators to secure the final necessary approval.

TransDigm Group (NYSE: TDG) has announced a definitive agreement to acquire Simmonds Precision Products from RTX Corporation (NYSE: RTX) for $765 million in cash, including tax benefits. Simmonds, based in Vergennes, Vermont, specializes in fuel & proximity sensing and structural health monitoring solutions for aerospace and defense markets.

The acquisition target generates approximately $350 million in annual revenue, with 40% derived from aftermarket sales. Simmonds employs around 900 people and is known for its highly engineered, proprietary components with significant aftermarket content and strong presence across major aerospace and defense platforms.

The transaction aligns with TransDigm's strategy of acquiring companies with proprietary products and substantial aftermarket presence. The acquisition will be financed through existing cash on hand and is subject to regulatory approvals in the United States and customary closing conditions.

Siyata Mobile (NASDAQ: SYTA) is approaching the completion of its $185 million merger with Core Gaming, expected to close in Q2 2025. Core Gaming brings a substantial portfolio of over 2,100 games with 790 million cumulative downloads and 43 million monthly active users (MAUs).

Core Gaming recently launched its AI COMIC App, an AI-powered visual content creation platform. The company has demonstrated strong financial growth, with revenue increasing from $13.2 million in 2021 to $57.0 million in 2023, and projected to reach $80.8 million in 2024. ValueScope projects 2026 revenue of $240.8 million, suggesting a potential combined company valuation between $722.4 million to $963.2 million.

Post-merger, Siyata Mobile will maintain a minimum 10% equity interest for legacy shareholders, supported by a special dividend. The merger positions the company in the rapidly expanding AI gaming market, which various research firms project to grow at CAGRs between 19-28.4% over the next decade.